#Ac 225 Therapy in India | Explore Tumblr Posts and Blogs

maheshposts-blog1 · 7 years

Text

Market Research Report of Alpha Emitters Market: Global Product Intelligence Industry

Albany/New York Pune/India, April, 2017.

Marketresearchdata.net has added a new report on Global Alpha Emitters Market. The report predicts the market size of Global Alpha Emitters Market is expected to reach XX billion by 2021.

The report covers the analysis of global as well as regional markets of Global Alpha Emitters Market. Moreover, the report gives insights into the factors that affect the global as well as regional performance of the market in the short run and in the long run.

The global market for alpha emitters is currently estimated to be valued at $107 million for the year 2015 and is poised to reach $283 million by the end of 2020. The CAGR during this period of forecast is 21.5%.

Browse full Report visit@

http://marketresearchdata.net/Reports/global-alpha-emitters-market

Alpha emitter radionuclide is considered to be a new approach to tackle cancer and related issues. Alpha emitter provides many advantages when compared to beta emitters and photon therapy, making it an increasingly preferred mode of treatment. As a result, this has caught the attention of major players interested in capitalizing the market potential. Alpha emitters are currently used in the process of Targeted Alpha Therapy (TAT), where in an alpha emitter radionuclide exposes a certain amount of radiation dose to tumor cells, at a very early stage or in the state of metastasis, and destroys the respective cancer cells. In contrast to chemotherapy, TAT allows easy discrimination between the healthy cells and cancer cells. This is helpful in reducing the side effects associated with Chemotherapy. The global market for alpha emitters can be segmented on the basis of radionuclide used – Terbium, Astatine, Bismuth, Actinium, Radium, Lead, Bismuth (Bi-213) and Others; type of medical application – Endocrine tumors, Lymphoma, Bone metastasis, Glioma, Melanoma, Pancreatic Cancer, Ovarian Cancer, Thyroid and Others; on the basis of Geography – North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. Major drivers contributing to growth of the market are increasing incidences of cardiac & cancer ailments, increased awareness about the potential benefits of targeted alpha therapy and increasing availability of radiopharmaceuticals. However, shorter life of radiopharmaceuticals, need for high capital investment, stringent regulatory framework and reimbursement issues are the major factors impacting market growth.

Table of Content

1. EXECUTIVE SUMMARY

2. INTRODUCTION 2.1 REPORT DESCRIPTION 2.2 RESEARCH METHODOLOGY

3. MARKET OVERVIEW 3.1 MARKET SEGMENTATION 3.2 MARKET DRIVERS 3.1.1 INCREASING INCIDENTS OF CANCER AND CARDIAC AILMENTS 3.1.2 INCREASING SPECT AND PET APPLICATIONS 3.1.3 GROWING PUBLIC AWARENESS FOR POTENTIAL BENEFITS OF NEW TREATMENTS LIKE TARGETED ALPHA THERAPY 3.2 MARKET CONSTRAINTS 3.2.1 SHORT HALF LIFE OF RADIOPHARMACEUTICALS 3.2.2 HIGH CAPITAL INVESTMENT 3.2.3 REGULATORY GUIDELINES 3.2.4. REIMBURSEMENT 3.3 OPPORTUNITIES 3.3.1 INCREASING IMAGING TECHNOLOGIES 3.3.2 POTENTIAL RADIOISOTOPES IN PIPELINE 3.3.3 INCREASING NEUROLOGICAL APPLICATIONS 3.3.4 CYCLOTRON BASED PRODUCTION 3.4 THREATS 3.4.1 SHUTDOWN OF NUCLEAR REACTORS

4. GLOBAL ALPHA EMITTERS MARKET SEGMENTATION 4.1 SEGMENTATION BY TYPE OF RADIONUCLIDE 4.1.1 TERBIUM (Tb-161) 4.1.2 ASTATINE (AT-211) 4.1.3 BISMUTH (BI-212) 4.1.4 ACTINIUM (AC-225) 4.1.5 RADIUM (RA-223) 4.1.6 LEAD (PB-212) 4.1.7 BISMUTH (BI-213) 4.1.8 OTHERS 4.2 SEGMENTATION BY APPLICATION 4.2.1 GLIOMA 4.2.2 MELANOMA 4.2.3 PANCREATIC CANCER 4.2.4 OVARIAN CANCER 4.2.5 THYROID 4.2.6 BONE METASTASIS 4.2.7 LYMPHOMA 4.2.8 ENDOCRINE TUMORS 4.3 SEGMENTATION BY GEOGRAPHY 4.3.1 NORTH AMERICA 4.3.1.1 US 4.3.1.2 CANADA 4.3.1.3 MEXICO 4.3.2 EUROPE 4.3.2.1 GERMANY 4.3.2.2 UK 4.3.2.3 FRANCE 4.3.2.4 SPAIN 4.3.2.5 ITALY 4.3.3 ASIA-PACIFIC 4.3.3.1 INDIA 4.3.3.2 CHINA 4.3.3.3 SOUTH KOREA 4.3.3.4 JAPAN 4.3.4 LATIN AMERICA 4.3.4.1 BRAZIL 4.3.4.2 CHILE 4.3.4.3 ARGENTINA 4.3.5 MIDDLE EAST & AFRICA

5. COMPETITIVE LANDSCAPE 5.1 MERGERS, ACQUISITIONS & SPIN OFFS 5.2 COLLABORATIONS 5.3 PRODUCT LAUNCHES

6. COMPANY PROFILES 6.1 IBA GROUP 6.2 LANTHEUS MEDICAL IMAGING 6.3 TRIAD ISOTOPES 6.4 SIEMENS HEALTHCARE (PETNET SOLUTIONS) 6.5 NTP RADIOISOTOPES 6.6 ACTINIUM PHARMACEUTICALS 6.7 BAYER HEALTHCARE

To make an enquiry about report visit:

http://marketresearchdata.net/Reports/MakeEnquiryRequest/17443.html

Reasons to buy this report: 1) Deep insights and comprehensive analysis of global and regional markets 2) complete coverage of key product types and application segments and their sub-segments through geographies and world market 3) Deep dive into the market share and recent developments of the key players in the industry. 4) Analysis and presentation of evolving market trends, patterns, technological advancements 5) Presentation of market dynamics and factors bearing control over the global and regional markets. 6) Competitive landscapes and insights 7) Opportunity mapping in terms of product developments, research and developments and technological advancements.

To know more about us Visit: http://marketresearchdata.net/Welcome/About.html Reasons to choose marketresearchdata.net 1) 24X7 sales support and free analyst time for post purchase queries. 2) Exclusive support from the analysts and industry experts possessing experience over 5 years in the industry 3) Long term relationship management and exclusivity benefits for our clients

To make sample request for report visit: http://marketresearchdata.net/Reports/MakeSampleRequest/17443.html Contact Us: USA/Canada Toll Free: +18006380796 Rest of the World: +919765091631 Email: [email protected] website: www.marketresearchdata.net

#Alpha Emitters Market size #Alpha Emitters Market trends #Alpha Emitters Market analysis #Alpha Emitters Market share #Alpha Emitters Market forecast

0 notes